The global Next Generation Sequencers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Next Generation Sequencers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Next Generation Sequencers market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Next Generation Sequencers in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Next Generation Sequencers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Illumina, Inc. (U.S.)
Thermo Fisher Scientific, Inc. (U.S.)
Pacific Biosciences of California, Inc. (U.S.)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (U.K.)
Otogenetics Corporation (U.S.)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Sequencing by Ligation (SBL)
Pyrosequencing
Single-Molecule Real-time (SMRT) Sequencing
Other

Segment by Application
Diagnostics
Drug Discovery
Biomarker Discovery
Personalized Medicine
Agriculture and Animal Research
Others